Olav Engebråten

5PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)GlycoconjugatesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 24, 2025
Spatial organization of the tumor-immune microenvironment in ER-positive breast cancer: remodeling during treatment and associations with clinical response.

Maria Aanesland Dahle, Jan-Lukas Førde, Eivind Valen Egeland

|Apr 29, 2025
The mechanisms of HER2 targeted ADCs are dependent on Rab GTPases.

Astrid Medhus, Kay Oliver Schink, Ane Sager Longva

|Jun 21, 2023
Liver X receptors induce antiproliferative effects in basal-like breast cancer.

Mads Haugland Haugen, Hedda von der Lippe Gythfeldt, Eivind Valen Egeland

|Feb 05, 2019
Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics.

Shakila Jabeen, Jaime A Espinoza, Lilly Anne Torland

Pageof 1